KaydedilenlerDerginizi ekleyin

Dergiler / E Journal of Cardiovascular Medicine / 2021 / Cilt: 9 - Sayı: 2

Total Serum Protein Predicted Mortality in Patients with St-elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention: Results of 8-Year Follow-up

Fatih KAHRAMAN
Ali Gökhan ÖZYILDIZ
Mustafa ÇETİN
Ahmet Seyda YILMAZ
Sayfa
122–129
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

While left ventricular ejection fraction (LVEF) (p=0.001), serum albumin (p=0.014), and TSP (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: ST-elevation myocardial infarction (STEMI) is globally one of the leading causes of mortality.
📊
Temel Bulgular & Veri:Materials and Methods: The patients diagnosed with STEMI between March 2007 and May 2009 were included in the study.
💡
Sonuç & Katkı:While left ventricular ejection fraction (LVEF) (p=0.001), serum albumin (p=0.014), and TSP (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2007 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: ST-elevation myocardial infarction (STEMI) is globally one of the leading causes of mortality. Determining modifiable mortality predictors to improve outcomes is critical. Total serum protein (TSP) is a composite indicator of immunity, nutrition, and inflammation and it plays a vital role in biological pathways contributing to cardiovascular diseases. TSP level has not been evaluated in patients with STEMI in the prediction of mortality previously. Materials and Methods: The patients diagnosed with STEMI between March 2007 and May 2009 were included in the study. TSP was obtained at admission to the hospital. Follow-up period of the study was 8 years and primary endpoint was all-cause mortality. Participants were separated according to the presence of mortality and clinical parameters compared between these two groups. Results: The mean age of the total 99 patients was 61±12.4 years and 82 (82.8%) of them were male. While left ventricular ejection fraction (LVEF) (p=0.001), serum albumin (p=0.014), and TSP (p

🔖

Bu Makaleye Atıf Yap

KAHRAMAN, F., ÖZYILDIZ, A. G., ÇETİN, M., YILMAZ, A. S. (2022). Total Serum Protein Predicted Mortality in Patients with St-elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention: Results of 8-Year Follow-up. E Journal of Cardiovascular Medicine, Cilt: 9 - Sayı: 2, 122–129. https://ajindex.com/articles/498219

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018;39:119-77
  2. Lev EI, Kornowski R, Vaknin-Assa H, et al. Comparison of the predictive value of four different risk scores for outcomes of patients with STelevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2008;102:6-11
  3. Chien SC, Chen CY, Lin CF, Yeh HI. Critical appraisal of the role of serum albumin in cardiovascular disease. Biomark Res 2017;5:31
  4. Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151:468-77
  5. Loprinzi PD, Addoh O. The gamma gap and all-cause mortality risk: considerations of physical activity. Int J Clin Pract 2016;70:625-9
  6. Wang M, Liu J, Ma C, et al. Synergistic association of serum albumin and globulin with coronary heart disease. J Atheroscler Thromb 2012;19:619- 32. 7. de Boer IH, Bangalore S, Benetos A, et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:1273-84
  7. Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021;42:1289-1367
  8. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005;41:1211-9
  9. Djoussé L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 2002;106:2919-24
  10. Oduncu V, Erkol A, Karabay CY, et al. The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coron Artery Dis 2013;24:88-94
  11. Akirov A, Masri-Iraqi H, Atamna A, Shimon I. Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients. Am J Med 2017;130:1465.e11-1465.e19
  12. Berg K, Jynge P, Bjerve K, Skarra S, Basu S, Wiseth R. Oxidative stress and inflammatory response during and following coronary interventions for acute myo